# OnCo record purdue-cancer-research (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/purdue-cancer-research/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "purdue-cancer-research" ;
  schema:name "Purdue Institute for Cancer Research"@en ;
  schema:alternateName "Purdue University Center for Cancer Research"@en ;
  schema:description "Purdue's NCI basic cancer centre, where Philip Low's folate- and PSMA-targeted ligands created Endocyte, the company Novartis bought for its radioligand programme."@en ;
  schema:url <https://onco.cc/institutions/purdue-cancer-research/>, <https://www.cancerresearch.purdue.edu> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.cancerresearch.purdue.edu>, <https://www.purdue.edu> ;
  schema:addressCountry "US" ;
  schema:addressLocality "West Lafayette, IN" ;
  schema:latitude "40.424"^^xsd:decimal ;
  schema:longitude "-86.921"^^xsd:decimal ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/fluorescence-guided-surgery/>, <https://onco.cc/technologies/peptide-drug-conjugate/> ;
  onco:targets <https://onco.cc/targets/psma/>, <https://onco.cc/targets/folr1/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:institutions <https://onco.cc/institutions/iu-simon/> ;
  onco:people <https://onco.cc/people/andrew-mesecar/> .